We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+5.64%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$11.3B
AUM Growth
+$589M
Cap. Flow
+$20.5M
Cap. Flow %
0.18%
Top 10 Hldgs %
17.02%
Holding
1,387
New
148
Increased
486
Reduced
533
Closed
92

Top Buys

Rank Stock Value
1
FTV icon
Fortive
FTV
+$47.4M
2
AGN
Allergan plc
AGN
+$38.9M
3
NVRO
NEVRO CORP.
NVRO
+$24.1M
4
NFLX icon
Netflix
NFLX
+$21.5M
5
WM icon
Waste Management
WM
+$21.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.99%
2 Technology 15.43%
3 Financials 11.87%
4 Industrials 11.27%
5 Consumer Discretionary 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KDP icon
926
Keurig Dr Pepper
KDP
$42.1B
$365K ﹤0.01%
3,994
+434
+12% +$41.1K
IMUX icon
927
Immunic
IMUX
$192M
$364K ﹤0.01%
149
LAD icon
928
Lithia Motors
LAD
$8.31B
$364K ﹤0.01%
3,806
+152
+4% +$12.8K
PFPT
929
DELISTED
Proofpoint, Inc.
PFPT
$363K ﹤0.01%
4,852
-17,038
-78% -$1.26M
TYPE
930
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$363K ﹤0.01%
16,399
+1,927
+13% +$41.9K
CVSA
931
Covista Inc
CVSA
$4.34B
$362K ﹤0.01%
+15,683
New +$350K
LMAT icon
932
LeMaitre Vascular
LMAT
$2.37B
$362K ﹤0.01%
18,269
+1,880
+11% +$32.8K
GG.WS.A
933
CALL
DELISTED
GOLDCORP INC SERIES A WARRANTS EXP 5/30/2007
GG.WS.A
$362K ﹤0.01%
+21,900
New +$362K
BEN icon
934
Franklin Resources
BEN
$17.9B
$360K ﹤0.01%
10,123
-2,713
-21% -$96K
ADSK icon
935
Autodesk
ADSK
$49.6B
$359K ﹤0.01%
4,963
-366
-7% -$23.1K
AFL icon
936
Aflac
AFL
$64.5B
$359K ﹤0.01%
10,002
+1,486
+17% +$54.1K
MLKN icon
937
MillerKnoll
MLKN
$1.64B
$358K ﹤0.01%
12,500
WSBC icon
938
WesBanco
WSBC
$4.01B
$358K ﹤0.01%
10,884
+1,661
+18% +$52.8K
MIXT
939
DELISTED
MIX TELEMATICS LIMITED
MIXT
$358K ﹤0.01%
56,020
+1,770
+3% +$9.47K
GEF icon
940
Greif
GEF
$4.93B
$357K ﹤0.01%
7,192
ACWX icon
941
iShares MSCI ACWI ex US ETF
ACWX
$11.7B
$356K ﹤0.01%
8,590
-1,920
-18% -$78.1K
MMS icon
942
Maximus
MMS
$3.27B
$356K ﹤0.01%
6,287
+547
+10% +$31.8K
GWX icon
943
State Street SPDR S&P International Small Cap ETF
GWX
$894M
$354K ﹤0.01%
11,282
-115
-1% -$3.5K
RLI icon
944
RLI Corp
RLI
$5.62B
$353K ﹤0.01%
10,328
-1,134
-10% -$39K
VGT icon
945
Vanguard Information Technology ETF
VGT
$147B
$353K ﹤0.01%
23,488
+4,384
+23% +$63.5K
BLV icon
946
Vanguard Long-Term Bond ETF
BLV
$5.76B
$351K ﹤0.01%
3,564
GLIN icon
947
VanEck India Growth Leaders ETF
GLIN
$95.7M
$351K ﹤0.01%
7,560
-150
-2% -$6.73K
TWOU
948
DELISTED
2U Inc
TWOU
$350K ﹤0.01%
305
-145
-32% -$151K
JCP
949
DELISTED
J.C. Penney Company, Inc.
JCP
$350K ﹤0.01%
37,909
+2,950
+8% +$28.1K
BMI icon
950
Badger Meter
BMI
$3.97B
$348K ﹤0.01%
10,392
-940
-8% -$32.5K

Similar funds

William Blair & Company's Q3 2016 Portfolio in Review

As of Q3 2016, William Blair & Company held 1,387 positions worth $11.3B, up 5.5% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

William Blair & Company's Q3 2016 filing shows 148 new, 486 increased, 533 reduced and 92 closed positions. Its largest new stake was Fortive: 1,476,720 shares worth $47.4M. The largest sale was Gilead Sciences, an estimated $45.3M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • William Blair & Company's largest Q3 2016 buy was Fortive: 1,476,720 shares worth $47.4M.
  • William Blair & Company added most to Allergan plc in Q3 2016, an estimated $38.9M increase.
  • William Blair & Company's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $45.3M.
  • William Blair & Company fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $6.24M.
  • William Blair & Company's ten largest holdings make up 17% of its $11.3B portfolio in Q3 2016.
  • William Blair & Company opened 148 new positions and closed 92 in Q3 2016.
  • William Blair & Company's portfolio value rose 5.5% quarter-over-quarter to $11.3B.

Based on William Blair & Company's 13F filing for Q3 2016, filed 14 Nov 2016.